AstraZeneca Aktie
WKN: 886715 / ISIN: US0463531089
10.11.2015 12:29:42
|
Dr. Reddy's Statement On Temporary Restraining Order For Esomeprazole Capsules
(RTTNews) - Dr. Reddy's Laboratories (RDY) in a statement issued today said that it has been made aware of an order passed by the District Court of Delaware, USA, granting a Temporary Restraining Order (TRO) with immediate effect on sales, delivery, transfer, or other disposition of its generic esomeprazole product in the US market.
Dr. Reddy's said it is complying with the order of the Court and simultaneously evaluating all possible options to resolve the matter at the earliest.
The order came about as a result of a motion moved by Astra Zeneca objecting to the usage of the colour Purple in the said generic product.
The order has been passed pending further hearing or trial. The Court has asked the parties to propose a next course of action and submit the same to the court. The court shall conduct a telephonic status conference on Thursday, November 12, 2015.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AstraZeneca PLC (spons. ADRs)mehr Nachrichten
01.04.25 |
Dienstagshandel in New York: NASDAQ 100 klettert am Dienstagnachmittag (finanzen.at) | |
01.04.25 |
Gewinne in New York: NASDAQ 100 mit Gewinnen (finanzen.at) | |
01.04.25 |
Anleger in New York halten sich zurück: NASDAQ 100 zum Start schwächer (finanzen.at) | |
31.03.25 |
Schwacher Wochentag in New York: NASDAQ 100 zum Ende des Montagshandels mit Abgaben (finanzen.at) | |
31.03.25 |
Börse New York: NASDAQ 100 am Nachmittag in Rot (finanzen.at) | |
31.03.25 |
Börse New York in Rot: NASDAQ 100 verbucht mittags Verluste (finanzen.at) | |
31.03.25 |
Angespannte Stimmung in New York: NASDAQ 100 beginnt die Montagssitzung mit Verlusten (finanzen.at) | |
28.03.25 |
Angespannte Stimmung in New York: NASDAQ 100 schwächelt zum Handelsende (finanzen.at) |
Analysen zu Dr. Reddy's Laboratories Ltd. (Spons. ADRS)mehr Analysen
Aktien in diesem Artikel
AstraZeneca PLC (spons. ADRs) | 67,50 | 0,75% |
|
Dr. Reddy's Laboratories Ltd. (Spons. ADRS) | 12,10 | 0,00% |
|